Circle Pharma to Present Late-Breaking Data at AACR 2025 Demonstrating Mechanism of Action for Novel Cyclin A/B RxL Inhibitors Circle Pharma, a clinical-stage biopharmaceutical company focused on ...

During the four years of the B.Pharmacy program, students study a variety of pharmacy-related subjects, including advanced mathematics, computer applications, pharmaceutical microbiology ...

Circle Pharma’s CID-078, an oral macrocycle Cyclin A/B RxL inhibitor, is being evaluated in a Phase 1 clinical study (NCT06577987). Presentation Details Title: Anti-cancer effect of Cyclin A/B ...

The former captain's unbeaten 76 on Sunday was his first 50 in seven matches this season and it helped secure their nine-wicket victory against Chennai Super Kings. Rohit has frequently lost his ...

The Indian government formed the National Council for Hotel Management and Catering Technology (Society) in 1982 as an independent organisation to supervise the growth and advancement of hotel ...

The prospect of pharma tariffs are also weighing on Roche and Novartis (NVS), which this month announced plans to invest $23 billion in the U.S. Roche has been expanding in the weight-loss drug ...

The pharmaceutical giant will invest in building new, cutting-edge R&D facilities while strengthening and growing its production plants in California, Massachusetts, Indiana, and Pennsylvania.

BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

As we close out the year, pharmaphorum's editorial team sat down together for a roundtable discussion of some of the biggest trends they tracked this year in the world of pharma. Join editor-in ...

Pharma isn’t exactly known for its creativity, and brand-building often takes a back seat in favour of traditional account-based marketing. One reason for that is the industry’s complexity.